| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
259,351 | 227,937 | 231,070 | 340,185 | 322,497 |
| Cost of Revenue
|
-95,876 | -96,440 | -118,734 | -158,169 | -137,848 |
|
Gross Profit
|
163,475 | 131,497 | 112,336 | 182,016 | 184,649 |
| Selling, General and Administrative Expenses
|
-112,542 | -108,773 | -175,696 | -234,553 | -174,141 |
|
Research and Development Expenses
|
-12,674 | -12,706 | -14,404 | -41,681 | -55,045 |
| Other Income/Expense, Operating
|
222 | 176 | 491 | 1,147 | 3,447 |
|
Operating Income/Expenses
|
-124,994 | -121,303 | -189,609 | -275,087 | -225,739 |
|
Total Operating Profit/Loss
|
38,481 | 10,194 | -77,273 | -93,071 | -41,090 |
| Net Investment Income
|
-8,084 | 224 | -65,866 | -7,290 | 18,014 |
| Irregular Income/Expenses
|
0 | 355 | 839 | 3,366 | 38,019 |
|
Other Income/Expense, Non-Operating
|
1,253 | 676 | 1,577 | 7,706 | 8,055 |
|
Non-Operating Income/Expenses, Total
|
-6,831 | 1,255 | -63,450 | 3,782 | 64,088 |
|
Pretax Income
|
31,650 | 11,449 | -140,723 | -89,289 | 22,998 |
|
Provision for Income Tax
|
-52 | -21 | -64 | 42 | -361 |
|
Net Income from Continuing Operations
|
31,598 | 11,428 | -140,787 | -89,247 | 22,637 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
31,598 | 11,428 | -140,787 | -89,247 | 22,637 |
|
Non-Controlling/Minority Interests
|
-481 | -262 | 4,160 | -733 | -694 |
|
Net Income after Non-Controlling/Minority Interests
|
31,117 | 11,166 | -136,627 | -89,980 | 21,943 |
|
Net Income Available to Common Stockholders
|
31,117 | 11,166 | -136,627 | -89,980 | 21,943 |
|
Diluted Net Income Available to Common Stockholders
|
31,117 | 11,166 | -136,627 | -89,980 | 21,943 |
| Basic EPS
|
0.75 | 0.28 | -3.25 | -2.15 | 0.53 |
| Diluted EPS
|
0.75 | 0.28 | -3.25 | -2.15 | 0.53 |
|
Basic Weighted Average Shares Outstanding
|
42,409.7750 | 42,338.8520 | 42,172.4240 | 41,722.2830 | 41,381.8890 |
|
Diluted Weighted Average Shares Outstanding
|
42,478.4240 | 42,400.9240 | 42,172.4240 | 41,722.2830 | 41,381.8890 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
31,650 | 11,449 | -140,723 | -89,289 | 22,998 |
|
EBITDA
|
31,650 | 21,874 | -130,573 | -76,050 | 38,526 |
|
Normalized EBITDA
|
32,658 | 12,550 | -140,245 | -83,306 | 37,767 |
|
Normalized Income
|
31,541 | 11,441 | -140,965 | -84,575 | 36,523 |
|
Total Unusual Items
|
0 | -1,231 | 61,958 | 9,213 | -40,693 |
12/31/2022 - 11/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade